| index | Title |
| 31 | Development and validation of a risk-prediction model for immune-related adverse events in patients with non-small-cell lung cancer receiving PD-1/PD-L1 inhibitors Author(s):Qing QIU, Chenghao WU, Wenxiao TANG, Longfei JI, Guangwei DAI, Yuzhen GAO, Enguo CHEN, Hanliang JIANG, Xinyou XIE, Jun ZHANG Clicked:4982 Download:4318 Cited:0 <Full Text> <PPT> 1941 Journal of Zhejiang University Science B 2023 Vol.24 No.10 P.935-942 DOI:10.1631/jzus.B2200631 |
| 32 | Roles of THEM4 in the Akt pathway: a double-edged sword Author(s):Wen XIE, Weidong LIU, Lei WANG, Bin ZHU, Cong ZHAO, Ziling LIAO, Yihan LI, Xingjun JIANG, Jie LIU, Caiping REN Clicked:3811 Download:3909 Cited:0 <Full Text> <PPT> 1540 Journal of Zhejiang University Science B 2024 Vol.25 No.7 P.541-556 DOI:10.1631/jzus.B2300457 |
| 33 | Depleting CBR1 increases chemosensitivity by reducing stemness and quiescence traits in non-small cell lung cancer Author(s):Weiwen LI, Jialu ZHAO, Weihong LAN, Xiaofei YE, Kejing YING Clicked:4058 Download:5649 Cited:0 <Full Text> <PPT> 977 Journal of Zhejiang University Science B 2025 Vol.26 No.12 P.1216-1232 DOI:10.1631/jzus.B2400509 |
| 34 | Emerging perspectives and promising solutions: lactylation modification in chemo- and radio-therapy of cancer Author(s):Jiaqi LIANG1,2, Rongrong LIU2, Shuo LIANG2, Zhicheng WANG2, Hongguang ZHAO1 Clicked:2943 Download:4559 Cited:0 <Full Text> Journal of Zhejiang University Science B In Press DOI: |
| 35 | In vivo 3D dose distribution verification for lung cancer: from rigid-body model to porcine lung Author(s):Yutao Zhang (张宇涛), Kai Xie (谢凯), Lintao Song (宋林涛), Jiewei Lai (赖杰伟), Haiping Zheng (郑海平), Qianjia Huang (黄仟甲), Hao Wang (王浩), Tao Lin (林涛), Liugang Gao (高留刚), Jiawei Sun (孙佳伟), Jianrong Dai (戴建荣) & Xinye Ni (倪昕晔) Clicked:935 Download:824 Cited:0 <Full Text> Bio-Design and Manufacturing 2025 Vol.8 No.6 P.994-1008 DOI:10.1631/bdm.2500077 |
